###begin article-title 0
###xml 39 43 <span type="species:ncbi:9696">Puma</span>
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
###end article-title 0
###begin p 1
###xml 49 53 <span type="species:ncbi:9696">Puma</span>
###xml 369 373 <span type="species:ncbi:9696">Puma</span>
###xml 467 472 <span type="species:ncbi:4932">yeast</span>
###xml 474 478 <span type="species:ncbi:9696">Puma</span>
###xml 619 623 <span type="species:ncbi:9696">Puma</span>
###xml 665 670 <span type="species:ncbi:9606">human</span>
###xml 808 812 <span type="species:ncbi:9696">Puma</span>
It is still unclear whether the BH3-only protein Puma (p53 up-regulated modulator of apoptosis) can prime cells to death and render antiapoptotic BH3-binding Bcl-2 homologues necessary for survival through its ability to directly interact with proapoptotic Bax and activate it. In this study, we provide further evidence, using cell-free assays, that the BH3 domain of Puma binds Bax at an activation site that comprises the first helix of Bax. We also show that, in yeast, Puma interacts with Bax and triggers its killing activity when Bcl-2 homologues are absent but not when Bcl-xL is expressed. Finally, endogenous Puma is involved in the apoptotic response of human colorectal cancer cells to the Bcl-2/Bcl-xL inhibitor ABT-737, even in conditions where the expression of Mcl-1 is down-regulated. Thus, Puma is competent to trigger Bax activity by itself, thereby promoting cellular dependence on prosurvival Bcl-2 family members.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 73 93 73 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adams and Cory, 2007</xref>
###xml 469 499 469 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Puthalakath and Strasser, 2002</xref>
###xml 775 795 775 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adams and Cory, 2007</xref>
###xml 941 960 941 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Petros et al., 2004</xref>
###xml 406 410 <span type="species:ncbi:9696">Puma</span>
###xml 520 526 <span type="species:ncbi:10090">murine</span>
The Bcl-2 family of proteins plays a major role in regulating apoptosis (Adams and Cory, 2007). Mammalian antiapoptotic members include Bcl-2, Bcl-xL, or Mcl-1 and display sequence conservation throughout four Bcl-2 homology domains (BH1-4). They oppose the multidomain proapoptotic proteins such as Bax and Bak, which share BH1, -2, and -3 in common with Bcl-2, and the BH3-only proteins (e.g., Bid, Bim, Puma [p53 up-regulated modulator of apoptosis], Bad, and Noxa; Puthalakath and Strasser, 2002). The resistance of murine cells lacking both Bax and Bak to cell death induction by multiple stimuli, including to BH3-only proteins, implies that antiapoptotic Bcl-2 homologues favor survival by antagonizing the recruitment by death signals and/or the activity of Bax/Bak (Adams and Cory, 2007). This prosurvival activity relies in great part on the ability of Bcl-2 homologues to engage the BH3 domains of Bax, Bak, or BH3-only proteins (Petros et al., 2004). Thus, the mechanisms through which Bcl-2 homologues allow survival is linked to those through which BH3-only proteins induce apoptosis upstream of Bax/Bak.
###end p 3
###begin p 4
###xml 136 155 136 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Willis et al., 2005</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">2007</xref>
###xml 163 183 163 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adams and Cory, 2007</xref>
###xml 295 314 295 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Petros et al., 2004</xref>
###xml 316 333 316 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Chen et al., 2005</xref>
###xml 335 353 335 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Certo et al., 2006</xref>
###xml 671 691 671 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Lalier et al., 2007a</xref>
###xml 1153 1170 1153 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Wang et al., 1996</xref>
###xml 1172 1191 1172 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kuwana et al., 2002</xref>
###xml 1193 1197 1193 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">2005</xref>
###xml 1199 1218 1199 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Letai, et al., 2002</xref>
###xml 1220 1241 1220 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 424 428 <span type="species:ncbi:9696">Puma</span>
###xml 926 930 <span type="species:ncbi:9696">Puma</span>
One model for BH3-induced apoptosis proposes that releasing Bax/Bak from survival Bcl-2 homologues is sufficient to promote cell death (Willis et al., 2005, 2007; Adams and Cory, 2007). This is achieved when the BH3-binding sites of diverse Bcl-2 homologues, which slightly differ in structure (Petros et al., 2004; Chen et al., 2005; Certo et al., 2006), are occupied by promiscuous BH3-only proteins (such as Bid, Bim, or Puma) or by the combination of more selective ones (such as Bad or Noxa). This model does not fully integrate the notion that native Bax is essentially inert and that substantial conformational changes are required for this protein to kill cells (Lalier et al., 2007a): induction of Bax-dependent apoptosis must rely on some Bax-activating signals. Another model for BH3-induced apoptosis proposes that such signals are provided by some BH3-only proteins: death agonists such as Bid, Bim, and possibly Puma harbor a BH3 domain that can promote ligand-induced activation of Bax, and other survival antagonist BH3-only proteins (Bad and Noxa) allow this process to occur by preventing Bcl-2 homologues to sequester death agonists (Wang et al., 1996; Kuwana et al., 2002, 2005; Letai, et al., 2002; Cartron et al., 2004a). The validity of this model has also been discussed, as it has been difficult to demonstrate the interaction between endogenous purported death agonist BH3-only proteins and Bax during the course of cell death.
###end p 4
###begin p 5
###xml 468 479 468 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Letai, 2008</xref>
###xml 619 642 619 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Oltersdorf et al., 2005</xref>
###xml 186 191 <span type="species:ncbi:9606">human</span>
Whether certain BH3-only proteins are factors that, independently from antiapoptotic Bcl-2 homologues, prime cells to Bax-dependent cell death is a key question regarding the biology of human cancer cells because (a) the apoptotic response of these cells, including to BH3-only proteins, generally depends in great part on Bax and much less on Bak to be efficient and (b) Bcl-2 homologues are highly expressed in these cells and contribute to their aberrant survival (Letai, 2008). These data, together with the recent development of a small molecule inhibitor of the BH3-binding activity of Bcl-xL and Bcl-2 (ABT-737; Oltersdorf et al., 2005), make timely the identification of proteins that contribute to induction of cell death induced by inhibition of Bcl-2 homologues.
###end p 5
###begin p 6
###xml 83 103 83 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Jeffers et al., 2003</xref>
###xml 105 127 105 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Villunger et al., 2003</xref>
###xml 233 254 233 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 291 309 291 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Certo et al., 2006</xref>
###xml 311 330 311 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Willis et al., 2007</xref>
###xml 508 524 508 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Kim et al., 2006</xref>
###xml 0 4 <span type="species:ncbi:9696">Puma</span>
###xml 145 149 <span type="species:ncbi:9696">Puma</span>
###xml 380 384 <span type="species:ncbi:9696">Puma</span>
###xml 615 619 <span type="species:ncbi:9696">Puma</span>
###xml 662 666 <span type="species:ncbi:9696">Puma</span>
###xml 763 767 <span type="species:ncbi:9696">Puma</span>
###xml 816 821 <span type="species:ncbi:9606">human</span>
Puma is an essential mediator of p53-dependent and -independent apoptosis in vivo (Jeffers et al., 2003; Villunger et al., 2003). We showed that Puma, and its BH3 domain in particular, might promote ligand-induced activation of Bax (Cartron et al., 2004a). This has been debated since then (Certo et al., 2006; Willis et al., 2007), even though recent evidence has suggested that Puma is a potent activator of cellular Bax and might function downstream of survival antagonist BH3-only proteins Bad and Noxa (Kim et al., 2006). In this study, we have analyzed the nature of the interaction between the BH3 domain of Puma and Bax, and we have investigated whether Puma exerts a Bax-activating function independently from Bcl-2 homologues and whether, consistently, Puma plays an active role when death is triggered in human cancer cells by inhibition of these survival proteins.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 18 22 <span type="species:ncbi:9696">Puma</span>
The BH3 domain of Puma physically and functionally interacts with Bax
###end title 8
###begin p 9
###xml 289 310 277 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 425 428 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 515 518 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 920 923 888 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 25 29 <span type="species:ncbi:9696">Puma</span>
###xml 217 221 <span type="species:ncbi:9696">Puma</span>
###xml 336 340 <span type="species:ncbi:9696">Puma</span>
We previously identified Puma as a binding partner of the first alpha helix of Bax (Bax Halpha1; residues 20-37) from a bacterial two-hybrid screen, and subsequent two-hybrid assays showed that the sole BH3 region of Puma (residues 127-150) interacts with Bax Halpha1 and full-length Bax (Cartron et al., 2004a). To investigate whether Puma BH3 can interact with cellular Bax, we used a biotinylated 24-mer peptide (Biot-PumaBH3) that encompasses this domain. Pull-down assays after incubation of 1 microM Biot-PumaBH3 with 500-microg lysates from glioblastoma cells expressing endogenous Bax (Bax-expressing glioblastoma multiforme [GBM; BeGBM]) showed that this peptide bound to endogenous Bcl-xL and also to Bax. Both interactions were inhibited by an excess of nonbiotinylated peptide (). In the absence of competing peptide, approximately2% of the initial Bax and 10% of initial Bcl-xL were pulled down by Biot-PumaBH3 (unpublished data).
###end p 9
###begin p 10
###xml 242 263 234 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 542 563 534 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 637 640 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 712 720 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 46 50 <span type="species:ncbi:9696">Puma</span>
###xml 341 345 <span type="species:ncbi:9696">Puma</span>
###xml 767 771 <span type="species:ncbi:9696">Puma</span>
In two-hybrid assays, the interaction between Puma (or its sole BH3 domain) and Bax (or its first alpha helix) is prevented by the alteration within Bax of an aspartate at position 33 (i.e., in the C-terminal end of Bax Halpha1) into an Ala (Cartron et al., 2004a). To confirm a role for this residue in the interaction of cellular Bax with Puma BH3, we used cell lysates made from originally Bax-deficient GBM (BdGBM) cells that were engineered to express wild-type Bax, the BaxD33A variant, or the BH3-mutated BaxK64A variant as a control (Cartron et al., 2004a). Wild-type Bax and BaxK64A but not BaxD33A were pulled down by Biot-PumaBH3 despite the comparable expression of each protein in the lysates used (Fig. 1 A). Thus, D33 is involved in the interaction of Puma BH3 with Bax. Incidentally, this also demonstrates the specificity of the interaction evaluated by this pull-down assay.
###end p 10
###begin p 11
###xml 0 96 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Role of the C-terminal end of Bax H&#945;1 in the interaction of Bax with the BH3 domain of Puma.</bold>
###xml 339 342 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 577 580 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 1226 1246 1218 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Suzuki et al. [2000]</xref>
###xml 1317 1320 1309 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 1634 1635 1612 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 91 95 <span type="species:ncbi:9696">Puma</span>
###xml 136 140 <span type="species:ncbi:9696">Puma</span>
###xml 1226 1232 <span type="species:ncbi:8164">Suzuki</span>
Role of the C-terminal end of Bax Halpha1 in the interaction of Bax with the BH3 domain of Puma. (A) Interaction of cellular Bax with a Puma BH3 peptide. Lysates from BdGBM(Bax-alpha), BdGBM(BaxD33A), and BdGBM(BaxK64A) cells expressing comparable amounts of Bax were used. Bax molecules pulled down from these lysates by biotinylated PumaBH3 were evaluated by Western blotting. (bottom) In each independent experiment, the amount of pulled down Bax was quantitated by densitometry and normalized to the maximum intensity. (B) Pepscan analysis. Interaction of biotinylated PumaBH3 with nitrocellulose membranes, on which were spotted 48 12-mer peptides covering the indicated sequence of Bax, was analyzed as described in Materials and methods. The top panel shows one representative autoradiogram. Peptides range from A1, which is the 12-mer peptide encompassing residues 1-12, to B24, which is the 12-mer peptide encompassing residues 95-106. In the bottom panel, the mean binding intensities (which were evaluated by densitometry and normalized to the maximum binding intensity) for three independent experiments using three different membranes are represented for each peptide. The positions of helices 1-4 (as defined in Suzuki et al. [2000]) are shown for illustration. (C) Interaction of cellular Bax with PumaBH3 in the presence of Bax Halpha1-Cter peptide. Pull-down experiments were performed as in A, using lysates from BeGBM cells. Where indicated, 10 microM Bax Halpha1-Cter was added to lysates before pull-down. (A and C) Data are mean +/- SEM of three independent experiments. P-values were assessed using a Student's t test. A.U., arbitrary unit; WB, Western blot; WT, wild type.
###end p 11
###begin p 12
###xml 183 200 183 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Brix et al., 1999</xref>
###xml 334 353 334 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Bellot et al., 2007</xref>
###xml 589 592 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 695 703 695 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 850 853 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 983 986 975 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 108 112 <span type="species:ncbi:9696">Puma</span>
###xml 1116 1120 <span type="species:ncbi:9696">Puma</span>
In an independent approach to map regions within the N-terminal end of Bax involved in its interaction with Puma BH3, we performed a linear peptide scan derived from epitope mapping (Brix et al., 1999). This approach helped to define the molecular motifs involved in the interaction between Bax and its mitochondrial receptor, TOM22 (Bellot et al., 2007). It was based on the use of nitrocellulose membranes on which 12-mer peptides, overlapping by 10 residues and covering the sequence of Bax comprised between residues 1-106, are covalently bound. Membranes were incubated with Biot-PumaBH3, and the presence of peptides bound to each Bax peptide was revealed using avidin-coupled peroxidase (Fig. 1 B). Peptides comprising residues 25-36, 27-38, and 29-40, which are located in the C-terminal end of Bax Halpha1, were strongly labeled by Biot-PumaBH3. Another region, which encompasses residues 89-100 and map to Bax Halpha4, showed some, albeit weaker, interaction with Biot-PumaBH3, but most other peptides exhibited no detectable interaction. Collectively, these data reveal a preferential interaction between Puma BH3 and the C-terminal end of Bax Halpha1.
###end p 12
###begin p 13
###xml 146 149 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</sup>
###xml 223 244 215 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 392 395 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 909 912 885 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 941 949 917 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1003 1006 979 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 19 23 <span type="species:ncbi:9696">Puma</span>
###xml 189 193 <span type="species:ncbi:9696">Puma</span>
###xml 577 581 <span type="species:ncbi:9696">Puma</span>
###xml 691 695 <span type="species:ncbi:9696">Puma</span>
###xml 1078 1081 <span type="species:ncbi:10116">rat</span>
The aforementioned Puma BH3-Bax Halpha1 interaction recalls our previous study showing that a peptide encompassing the first helix of Bax (Halpha1Bax) could prevent the interaction between Puma and in vitro-translated Bax (Cartron et al., 2004a). Likewise, an excess of this 20-mer peptide but not that of a mutant peptide bearing the D33A mutation prevented the interaction between Biot-PumaBH3 and cellular Bax in pull-down assays (Fig. S1 B). We inferred from Pepscan analysis that contiguous residues at the C-terminal end of Bax Halpha1 might suffice to interact with the Puma BH3 domain and that a shorter peptide encompassing these residues might also prevent the interaction between Puma BH3 and cellular Bax. Thus, we analyzed the effects of a 7-mer peptide (Halpha1 C terminus [Halpha1-Cter]; residues 31-37) in pull-down assays. 10 microM of this peptide inhibited the interaction between Biot-PumaBH3 and Bax from BeGBM lysates (Fig. 1 C). Of note, it also inhibited the ability of Biot-PumaBH3 to interact with Bax present in the cytosolic fraction of immortalized rat fibroblasts, whereas a mutant 7-mer peptide carrying the D33A mutation or other 7-mer peptides comprising adjacent residues 25-31 or residues 92-98 did not (unpublished data).
###end p 13
###begin p 14
###xml 192 195 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 356 359 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 368 389 364 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 479 482 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 546 549 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 688 691 680 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 823 826 815 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 900 919 892 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Kuwana et al., 2005</xref>
###xml 921 939 913 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Certo et al., 2006</xref>
###xml 1298 1317 1290 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Manero et al., 2006</xref>
###xml 1394 1414 1386 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Cartron et al., 2003</xref>
###xml 1416 1421 1408 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">2004a</xref>
###xml 1435 1438 1427 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 1611 1617 1603 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1818 1821 1810 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 1885 1891 1871 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1967 1970 1953 1956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2003 2006 1989 1992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2176 2179 2158 2161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2236 2242 2218 2224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 2290 2293 2272 2275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2468 2471 2450 2453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2503 2509 2481 2487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 2625 2628 2599 2602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2751 2757 2721 2727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 2852 2855 2818 2821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 2970 2973 2936 2939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 3592 3595 3550 3553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 3597 3617 3555 3575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Cartron et al., 2002</xref>
###xml 73 77 <span type="species:ncbi:9696">Puma</span>
###xml 1188 1193 <span type="species:ncbi:9606">human</span>
###xml 3290 3294 <span type="species:ncbi:9696">Puma</span>
###xml 3313 3317 <span type="species:ncbi:9696">Puma</span>
###xml 3579 3583 <span type="species:ncbi:9696">Puma</span>
###xml 3684 3688 <span type="species:ncbi:9696">Puma</span>
We used Halpha1-Cter as a tool to investigate whether the interaction of Puma BH3 with Bax accounts for the ability of the former to promote the activity of the latter. We have shown that PumaBH3 can induce an apoptotic-like change of conformation in in vitro-translated Bax and trigger its mitochondrial activity, whereas nonactivator peptides such as BadBH3 do not (Cartron et al., 2004a). In dose-response experiments, we detected no differences between the efficiency of PumaBH3 and that of other purported activator BH3 peptides (such as BidBH3) to impact on Bax conformation and activity (Fig. S1 C). Halpha1-Cter inhibited, in a dose-dependent manner, this cell-free effect of PumaBH3 on Bax, indicating that it relies on a physical interaction between the two molecules (Fig. S1 D). The reason why an impact of PumaBH3 on Bax activity has been difficult to detect in other cell-free systems (Kuwana et al., 2005; Certo et al., 2006) remains to be elucidated. In an integrated approach to measure Bax apoptogenicity, we also measured induction of cell death by the microinjection of recombinant Bax, which had been preincubated with various peptides. Experiments were performed in human glioblastoma cells in which Bax expression was selectively knocked down by RNA interference (GBM shBax; Manero et al., 2006) to avoid interference of endogenous Bax. Consistent with previous studies (Cartron et al., 2003, 2004a), 100 nM PumaBH3 only induced weak, background cell death 6 h after its microinjection in GBM shBax, whereas it induced significant cell death amounts in control cells (GBM scramble [scr]; Fig. 2). Although microinjection of 100 nM recombinant Bax by itself was mostly inefficient at inducing cell death in GBM shBax cells, microinjection of 100 nM Bax that had been preincubated with 100 nM PumaBH3 (for 60 min at 37degreesC) did promote significant cell death (Fig. 2). The ability to trigger Bax induction of cell death was also found for BidBH3, but it was not observed for BadBH3 (Fig. S1 E), indicating that this short-term system assays the apoptogenicity of the injectate at the time of microinjection. Halpha1-Cter diminished the ability of PumaBH3 to promote cell death in Bax-expressing, GBM scr cells (Fig. 2). Moreover, when this peptide was added to PumaBH3 before incubation with recombinant Bax and microinjection in GBM shBax cells, no significant cell death could be detected, indicating that enhancement of Bax activity by PumaBH3 was inhibited by Halpha1-Cter (Fig. 2). Importantly, when Halpha1-Cter was added to the microinjection preparation after Bax had been incubated with PumaBH3, the resulting mixture proved as efficient at inducing cell death in GBM shBax cells as the mixture without Halpha1-Cter (Fig. 2). Thus, in this system, Halpha1-Cter exerts an inhibitory effect during the incubation of PumaBH3 with Bax, but it has no effect on the cell response to the mixture. In contrast, recombinant Bcl-xL prevented PumaBH3 activation of Bax when added not only before but also after incubation of the peptide with Bax, supporting the idea that Bcl-xL can exert control over both ligand-induced Bax activation and Bax activity (Fig. S1 F). Importantly, microinjected Halpha1-Cter also prevented induction of cell death by overexpression of Puma in GBM cells, and Puma-dependent induction of cell death by Adriamycin in HCT116 cells (). These observations, together with our previous study showing that ectopic wild-type Bax-alpha or BaxK64A but not ectopic BaxD33A restores the sensitivity of Bax-deficient glioblastoma cells to Puma and PumaBH3 (Cartron et al., 2002), are in strong agreement with the notion that the interaction of Puma BH3 with Bax Halpha1 enhances Bax activity and promotes cell death.
###end p 14
###begin p 15
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Functional cooperation between Puma<sup>BH3</sup> and Bax.</bold>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 309 312 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 353 356 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 640 641 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Functional cooperation between PumaBH3 and Bax. The indicated GBM cells were microinjected with combinations of 100 nM PumaBH3, 1 microM Halpha1-Cter, and/or 100 nM recombinant Bax together with a fluorescent microinjection marker (0.5% FITC-dextran 40S). Where indicated, Halpha1-Cter was incubated with PumaBH3 before incubation with Bax or after PumaBH3 was incubated with Bax. The percentage of properly microinjected (i.e., fluorescent) cells exhibiting morphological features of cell death was assayed 6 h after microinjection. Data are mean +/- SEM of at least three independent experiments. P-values were assessed using a Student's t test.
###end p 15
###begin title 16
###xml 0 4 <span type="species:ncbi:9696">Puma</span>
###xml 36 41 <span type="species:ncbi:4932">yeast</span>
Puma cooperates with Bax to promote yeast cell death in a Bcl-xL-sensitive manner
###end title 16
###begin p 17
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 381 401 381 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Priault et al., 2003</xref>
###xml 403 423 403 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Arokium et al., 2004</xref>
###xml 603 604 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 606 626 606 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Arokium et al., 2004</xref>
###xml 791 799 791 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 905 913 905 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 930 931 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 941 949 941 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 1063 1083 1063 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Arokium et al., 2004</xref>
###xml 1129 1137 1129 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 23 27 <span type="species:ncbi:9696">Puma</span>
###xml 192 197 <span type="species:ncbi:4932">yeast</span>
###xml 268 273 <span type="species:ncbi:4932">yeast</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:4932">yeast</span>
###xml 694 698 <span type="species:ncbi:9696">Puma</span>
###xml 735 739 <span type="species:ncbi:9696">Puma</span>
###xml 829 834 <span type="species:ncbi:4932">yeast</span>
###xml 874 878 <span type="species:ncbi:9696">Puma</span>
###xml 887 892 <span type="species:ncbi:4932">yeast</span>
###xml 974 978 <span type="species:ncbi:9696">Puma</span>
To investigate whether Puma and Bax can physically interact and functionally cooperate to promote cell death in the absence of Bcl-2 homologues, we analyzed the effects of their expression in yeast, which express no recognized Bcl-2 family proteins. When expressed in yeast, full-length untagged human Bax remains cytosolic and induces neither cytochrome c release nor cell death (Priault et al., 2003; Arokium et al., 2004). Nevertheless, conformational changes of the protein caused by substitution of critical residues can promote mitochondrial translocation and the subsequent release of cytochrome c (Arokium et al., 2004). We generated yeast strains that express galactose-inducible Bax, Puma, or both. Although the induction of Puma only (not depicted) or that of wild-type Bax only (Fig. 3 A) had no detectable effect on yeast viability, the coexpression of Bax and Puma induced yeast cell death (Fig. 3 A) and cytochrome c release (Fig. 3 C). Cell death induced by Puma and Bax, as previously reported for that induced by active substituted Bax mutants (Arokium et al., 2004), was prevented by the expression of Bcl-xL (Fig. 3 A).
###end p 17
###begin p 18
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Interaction of Bax and Puma in yeast.</bold>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 23 27 <span type="species:ncbi:9696">Puma</span>
###xml 31 36 <span type="species:ncbi:4932">yeast</span>
###xml 42 47 <span type="species:ncbi:4932">Yeast</span>
###xml 73 77 <span type="species:ncbi:9696">Puma</span>
###xml 122 126 <span type="species:ncbi:9696">Puma</span>
###xml 163 168 <span type="species:ncbi:4932">yeast</span>
###xml 291 296 <span type="species:ncbi:4932">Yeast</span>
###xml 329 333 <span type="species:ncbi:9696">Puma</span>
###xml 445 449 <span type="species:ncbi:9696">Puma</span>
###xml 534 539 <span type="species:ncbi:4932">yeast</span>
###xml 623 627 <span type="species:ncbi:9696">Puma</span>
###xml 674 679 <span type="species:ncbi:4932">yeast</span>
###xml 735 739 <span type="species:ncbi:9696">Puma</span>
###xml 853 857 <span type="species:ncbi:9696">Puma</span>
###xml 903 907 <span type="species:ncbi:9696">Puma</span>
###xml 928 933 <span type="species:ncbi:4932">yeast</span>
###xml 976 980 <span type="species:ncbi:9696">Puma</span>
###xml 994 998 <span type="species:ncbi:9696">Puma</span>
###xml 1008 1012 <span type="species:ncbi:9696">Puma</span>
Interaction of Bax and Puma in yeast. (A) Yeast cell survival after Bax, Puma, and Bcl-xL coexpression. Induction of Bax, Puma, and/or Bcl-xL in the corresponding yeast cells and survival assays at the indicated time after induction were performed as described in Materials and methods. (B) Yeast cell survival after BaxD33A and Puma coexpression. The experiment was performed as in A. (C) Cytochrome c release after wild-type Bax, BaxD33A, and Puma coexpression. Cytochrome (Cyt.) content in mitochondria isolated from the indicated yeast cells 14 h after induction was measured as described in Materials and methods. (D) Puma interaction with wild-type Bax and BaxD33A in yeast. Extracts from cells coexpressing Bax (or BaxD33A) and Puma were immunoprecipitated with anti-Bax antibody, and immunoprecipitates were analyzed for the presence of Bax and Puma by Western blotting. (E) Effect of Bcl-xL on Puma-Bax interactions in yeast. Extracts from cells coexpressing Bax and Puma, BaxD33A and Puma, or Bax, Puma, and Bcl-xL were treated as in D. (A-C) Data are mean +/- SEM of three independent experiments.
###end p 18
###begin p 19
###xml 194 195 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 230 245 226 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, B and C</xref>
###xml 314 334 310 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Cartron et al., 2005</xref>
###xml 336 356 332 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Arokium et al., 2007</xref>
###xml 515 530 511 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, B and C</xref>
###xml 55 59 <span type="species:ncbi:9696">Puma</span>
###xml 103 108 <span type="species:ncbi:4932">yeast</span>
###xml 411 416 <span type="species:ncbi:4932">yeast</span>
###xml 466 470 <span type="species:ncbi:9696">Puma</span>
To evaluate whether the functional cooperation between Puma and Bax involved Bax Halpha1, we then used yeast strains expressing galactose-inducible BaxD33A. This mutant promoted some cytochrome c release and cell death by itself (Fig. 3, B and C), most likely owing to a partial unfolding induced by the mutation (Cartron et al., 2005; Arokium et al., 2007). Nevertheless, the deleterious effects of BaxD33A in yeast cells were not stimulated by the coexpression of Puma, even at early time points after induction (Fig. 3, B and C).
###end p 19
###begin p 20
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 359 367 359 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 107 111 <span type="species:ncbi:9696">Puma</span>
###xml 204 208 <span type="species:ncbi:9696">Puma</span>
###xml 241 246 <span type="species:ncbi:4932">yeast</span>
###xml 276 280 <span type="species:ncbi:9696">Puma</span>
###xml 376 380 <span type="species:ncbi:9696">Puma</span>
Coimmunoprecipitation experiments were performed to investigate whether the functional cooperation between Puma and Bax coincided with a physical interaction between these two proteins. Wild-type Bax and Puma interacted with each other in a yeast context, whereas BaxD33A and Puma could not (Fig. 3 D). Moreover, Bcl-xL expression inhibited this interaction (Fig. 3 E). Thus, Puma and Bax physically interact and functionally cooperate by a Bax Halpha1-dependent, Bcl-xL-sensitive process, even in a cellular context that lacks known equivalents of the mammalian apoptotic machinery.
###end p 20
###begin title 21
###xml 0 4 <span type="species:ncbi:9696">Puma</span>
Puma plays a role in Bax-dependant apoptosis induced by inhibition or down-regulation of Bcl-xL
###end title 21
###begin p 22
###xml 480 503 480 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Oltersdorf et al., 2005</xref>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup></italic>
###xml 653 656 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 663 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 650 663 650 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup>Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 671 674 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 677 680 677 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 668 680 668 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup>Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 682 690 682 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 64 68 <span type="species:ncbi:9696">Puma</span>
###xml 152 156 <span type="species:ncbi:9696">Puma</span>
###xml 249 253 <span type="species:ncbi:9696">Puma</span>
###xml 355 359 <span type="species:ncbi:9696">Puma</span>
###xml 516 521 <span type="species:ncbi:9606">human</span>
###xml 623 627 <span type="species:ncbi:9696">Puma</span>
###xml 656 660 <span type="species:ncbi:9696">Puma</span>
We investigated whether the aforementioned activation of Bax by Puma could take place in mammalian cells. As this activation involves the BH3 domain of Puma and is prevented by Bcl-xL, we reasoned that its occurrence in mammalian cells would define Puma as an actor of cell death that ensues when Bcl-2 homologues are inhibited. Thus, we analyzed whether Puma plays a role when cell death is induced by ABT-737, a potent inhibitor of the BH3-binding activity of Bcl-xL and Bcl-2 (Oltersdorf et al., 2005), using the human colorectal cancer cell line HCT116 p21-/- and its isogenic counterparts in which genetic ablation of Puma or Bax was performed (p21-/-Puma-/- and p21-/-Bax-/-; Fig. 4 A).
###end p 22
###begin p 23
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Role of endogenous Puma in the biological activity of ABT-737.</bold>
###xml 804 805 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1385 1386 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 19 23 <span type="species:ncbi:9696">Puma</span>
###xml 156 160 <span type="species:ncbi:9696">Puma</span>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 601 606 <span type="species:ncbi:9606">human</span>
###xml 932 937 <span type="species:ncbi:9606">human</span>
Role of endogenous Puma in the biological activity of ABT-737. (A) Expression of Bcl-2 family members in HCT116-derived cell lines. Expression of 50 microg Puma, Bax, and Bcl-xL in lysates from the indicated cells was analyzed by Western blotting. WB, Western blot. (B) Induction of cell death by ABT-737 in human colorectal cancer cells. The indicated cells were incubated with the indicated concentration of ABT-737 for 24 h, and induction of cell death was assayed by a trypan blue-staining procedure. Data are mean +/- SEM of four independent experiments. (C) Induction of apoptosis by ABT-737 in human colorectal cancer cells. The indicated cells were incubated with the indicated concentration of ABT-737 for 24 h before immunocytochemical analysis of the percentage of cells exhibiting cytochrome c release and caspase 3 activation. Data are mean +/- SEM of three independent experiments. (D) Long-term effects of ABT-737 on human colorectal cells. The indicated cells were treated for 2 wk with the indicated concentration of ABT-737 before analysis of viable clones by crystal violet staining. Data are mean +/- SEM of at least three independent experiments and are expressed as a percentage of the number of colonies formed in untreated dishes. One experiment representative of three independent ones is shown in the top panel. (B-D) P-values were assessed using a Student's t test.
###end p 23
###begin p 24
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 150 158 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 223 226 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 220 226 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 420 423 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 416 423 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 558 566 554 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 680 681 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 808 809 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 889 892 885 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 885 892 881 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 922 930 918 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 993 994 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1033 1036 1025 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1030 1036 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 1096 1097 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 37 41 <span type="species:ncbi:9696">Puma</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 416 420 <span type="species:ncbi:9696">Puma</span>
###xml 885 889 <span type="species:ncbi:9696">Puma</span>
###xml 1050 1054 <span type="species:ncbi:9696">Puma</span>
###xml 1205 1209 <span type="species:ncbi:9696">Puma</span>
###xml 1283 1287 <span type="species:ncbi:9696">Puma</span>
###xml 1362 1366 <span type="species:ncbi:9696">Puma</span>
###xml 1545 1549 <span type="species:ncbi:9696">Puma</span>
###xml 1595 1599 <span type="species:ncbi:9696">Puma</span>
###xml 1656 1660 <span type="species:ncbi:9696">Puma</span>
###xml 1901 1905 <span type="species:ncbi:9696">Puma</span>
###xml 2037 2041 <span type="species:ncbi:9696">Puma</span>
We analyzed the response of control, Puma-/-, and Bax-/- cells to 24-h treatment with increasing concentrations (1-10 microM) of ABT-737. As shown in Fig. 4 B, ABT-737 induced dose-dependent cell death in control cells. Bax-/- cells were completely resistant to this short-term treatment at all concentrations tested, further underscoring the importance of Bax in the apoptotic response of these human cancer cells. Puma-/- cells exhibited some cell death response at high concentrations of ABT-737, but it was much lower than that induced in control cells (Fig. 4 B). A closer examination of the death pathways involved was performed by immunocytochemical analysis of cytochrome c localization and caspase 3 activation (using a conformation-specific antibody). The percentage of cells exhibiting cytochrome c release and caspase 3 activation after ABT-737 treatment was much lower in Puma-/- cells than in control cells (Fig. 4 C). ABT-737 at 10 microM had no detectable effect on cytochrome c release or caspase 3 activation in Bax-/- cells. Thus, Puma is implicated in induction of cytochrome c release, caspase 3 activation, and apoptotic cell death by ABT-737. As we could not detect any increase in Puma expression upon ABT-737 treatment (), we infer that endogenous levels of Puma are sufficient to mediate these effects. We checked that the knockdown of Puma expression in control HCT116 cells by RNA interference conferred resistance to ABT-737-induced caspase 3 activation and cell death (Fig. S3, B and C). Notably, the resistance of Puma knockdown cells was not as marked as that of Puma knockout cells, suggesting that the remaining levels of Puma in the knockdown cells could still mediate ABT-737-induced cell death. Microinjection of Halpha1-Cter peptide into control HCT116 cells significantly inhibited ABT-737 induction of cell death (Fig. S3 D), further supporting the notion that Puma is involved in this process. RNA interference experiments and microinjection assays using Halpha1-Cter also showed that endogenous Puma contributes to the apoptotic response of primary GBM cells to ABT-737 (Fig. S3, E-G).
###end p 24
###begin p 25
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 337 345 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 352 355 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 348 355 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 508 511 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 505 511 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 19 23 <span type="species:ncbi:9696">Puma</span>
###xml 94 98 <span type="species:ncbi:9696">Puma</span>
###xml 348 352 <span type="species:ncbi:9696">Puma</span>
To analyze whether Puma was involved in long-term effects of ABT-737 on cell growth, control, Puma-/-, and Bax-/- HCT116 cells were seeded at a low density and treated for 2 wk with 1-10 microM ABT-737 before visualization of viable clones. ABT-737 significantly affected the clonogenicity of control cells at all concentrations tested (Fig. 4 D). Puma-/- cells were strikingly more resistant to these long-term effects, as only 10 microM ABT-737 had a major effect on their growth. Because the growth of Bax-/- cells was also affected at this concentration, the implication of Bax-independent mechanisms, of nonapoptotic growth inhibitory mechanisms, and/or that of off-target effects of ABT-737 cannot be ruled out when high concentrations are used for long periods of treatment.
###end p 25
###begin p 26
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 480 488 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 756 771 756 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, B and C</xref>
###xml 786 802 786 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 (B and C)</xref>
###xml 808 811 808 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 804 811 804 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 819 822 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 816 822 816 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 1152 1160 1152 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1793 1814 1789 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Cartron et al., 2004b</xref>
###xml 169 173 <span type="species:ncbi:9696">Puma</span>
###xml 263 267 <span type="species:ncbi:9696">Puma</span>
###xml 804 808 <span type="species:ncbi:9696">Puma</span>
###xml 1102 1106 <span type="species:ncbi:9696">Puma</span>
###xml 1306 1310 <span type="species:ncbi:9696">Puma</span>
###xml 1837 1841 <span type="species:ncbi:9696">Puma</span>
###xml 1993 1997 <span type="species:ncbi:9696">Puma</span>
The aforementioned experiments suggest that some survival proteins targeted by ABT-737 constitutively maintain survival of the cells used in this study by counteracting Puma. We analyzed the acute effects of RNA interference-mediated Bcl-xL knockdown in control, Puma-/-, and Bax-/- cells. We used a recombinant lentivirus that expresses GFP together with a short hairpin RNA targeting Bcl-xL (shBcl-xL) and infection conditions that lead to a profound loss of Bcl-xL expression (Fig. 5 A). Under these conditions, Bcl-xL knockdown induced the appearance of a significant number of cells with active caspase 3 2 d after infection and massive cell death 3 d after infection in control cells, whereas infection with a control (scr) lentivirus had no effect (Fig. 5, B and C). As shown in Fig. 5 (B and C), Puma-/- and Bax-/- cells were refractory to caspase 3 activation and cell death induced by lentivirus-mediated down-regulation of Bcl-xL. Of note, a recombinant lentivirus targeting Bcl-2 had a strikingly weaker effect on cell viability than the shBcl-xL lentivirus, but its feeble effect was also Puma dependent (unpublished data). Interestingly, Fig. 5 A suggests that cell death induced by Bcl-xL knockdown in control cells may be slowed down by the unexpected ability of this knockdown to decrease Puma expression. The mechanism involved, which was also detected in Bax-deficient cells, remains to be characterized. It should also be noted that knockdown of Bcl-xL in control cells provoked the apparition of a truncated form of Bax of an apparent molecular mass of 18 kD. This may be a consequence of the induction of cell death, as this truncation, which has been reported in many cases of apoptosis induction and results in the removal of Bax Halpha1 from the rest of the molecule (Cartron et al., 2004b), was not observed in Puma-deficient cells. In all cases, the view that emerges from these assays is that Bcl-xL acts in an ABT-737-sensitive manner to counteract a constitutive Puma-related death signal.
###end p 26
###begin p 27
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Role of endogenous Puma in the induction of apoptotic cell death by down-regulation of Bcl-xL in human cancer colorectal cells.</bold>
###xml 927 935 927 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1059 1060 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 19 23 <span type="species:ncbi:9696">Puma</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 259 263 <span type="species:ncbi:9696">Puma</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
Role of endogenous Puma in the induction of apoptotic cell death by down-regulation of Bcl-xL in human cancer colorectal cells. (A) Expression of Bcl-2 family members in HCT116-derived cell lines after down-regulation of Bcl-xL. Western blot (WB) analysis of Puma, Bax, Bcl-xL, and Mcl-1 in lysates from the indicated cells was performed 3 d after infection with the indicated recombinant lentivirus. The asterisk indicates a truncated form of Bax of 18 kD. (B) Induction of cell death by down-regulation of Bcl-xL in human colorectal cancer cells. The indicated cells were infected with the indicated lentivirus, and induction of cell death was assayed by a trypan blue-staining procedure 3 d later. (C) Activation of caspase 3 by down-regulation of Bcl-xL in human colorectal cancer cells. The indicated cells were infected with the indicated recombinant lentivirus, and activation of caspase 3 was evaluated as described in Fig. 4 B 2 d later. (B and C) Data are mean +/- SEM of three independent experiments. P-values were assessed using paired Student's t tests. ShRNA, short hairpin RNA.
###end p 27
###begin title 28
###xml 0 4 <span type="species:ncbi:9696">Puma</span>
Puma mediates apoptosis induced by pharmacological inhibition of Bcl-xL combined with Mcl-1 down-regulation
###end title 28
###begin p 29
###xml 32 55 32 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Oltersdorf et al., 2005</xref>
###xml 109 126 109 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Chen et al., 2005</xref>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 661 680 661 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Maiuri et al., 2007</xref>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 838 846 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 994 997 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 990 997 986 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 1170 1178 1166 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 62 66 <span type="species:ncbi:9696">Puma</span>
###xml 154 158 <span type="species:ncbi:9696">Puma</span>
###xml 345 349 <span type="species:ncbi:9696">Puma</span>
###xml 990 994 <span type="species:ncbi:9696">Puma</span>
###xml 1187 1191 <span type="species:ncbi:9696">Puma</span>
ABT-737 does not inhibit Mcl-1 (Oltersdorf et al., 2005), and Puma does interact with this survival protein (Chen et al., 2005). Thus, the involvement of Puma in the aforementioned deleterious effects of ABT-737 may rely on the ability of this protein to counteract Mcl-1 rather than on its ability to activate Bax directly. We analyzed whether Puma was still involved in the induction of death by ABT-737 in cells devoid of Mcl-1. Because we were unable to produce a lentivirus construct that would significantly knock down Mcl-1 in HCT116 cells, we used a previously published procedure in which siRNAs targeting Mcl-1 were transiently transfected (Fig. 6 A; Maiuri et al., 2007). Mcl-1 knockdown by transfection of siRNAs induced only a modest increase in the amount of cells with released cytochrome c and active caspase 3 by itself (Fig. 6 B), but it allowed a more efficient induction of these apoptotic events by a 24-h treatment with 1 microM ABT-737 in control cells. In contrast, Puma-/- cells were not sensitized to ABT-737-induced cell death by Mcl-1 knockdown, and remained significantly more resistant to ABT-737-induced cell death under these conditions (Fig. 6 B). Thus, Puma still exerts proapoptotic activity when Mcl-1 is down-regulated and Bcl-xL is inhibited.
###end p 29
###begin p 30
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Role of Mcl-1 in Puma-dependent apoptosis induced by ABT-737.</bold>
###xml 311 312 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 377 385 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1041 1042 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 17 21 <span type="species:ncbi:9696">Puma</span>
###xml 205 209 <span type="species:ncbi:9696">Puma</span>
Role of Mcl-1 in Puma-dependent apoptosis induced by ABT-737. (A and B) Down-regulation of Mcl-1. The indicated cells were transfected with the indicated siRNA. 48 h later, Western blot analysis of Mcl-1, Puma, Bax, and Bcl-xL (A) and treatment with 1 microM ABT-737 (B) were performed. Induction of cytochrome c release and caspase 3 activation were analyzed as described for Fig. 4 B. NT, not treated. (C) Overexpression of Mcl-1. The indicated cells were transfected with the indicated plasmid. 24 h later, cells were treated with 10 microM ABT-737 for an additional 24 h. Immunocytochemical analysis of active caspase 3 and of Flag expression was then performed. For Flag-Mcl-1-transfected cells, the percentage of Flag-positive cells that also stained positive for active caspase 3 was evaluated. For mock-transfected cells, the percentage of cells that stained positive for active caspase 3 was evaluated in random populations. (B and C) Data are mean +/- SEM of three independent experiments. P-values were assessed using a Student's t test.
###end p 30
###begin p 31
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 140 144 <span type="species:ncbi:9696">Puma</span>
###xml 217 221 <span type="species:ncbi:9696">Puma</span>
###xml 412 416 <span type="species:ncbi:9696">Puma</span>
###xml 628 632 <span type="species:ncbi:9696">Puma</span>
###xml 786 790 <span type="species:ncbi:9696">Puma</span>
###xml 808 812 <span type="species:ncbi:9696">Puma</span>
Conversely, we analyzed whether increased expression of Mcl-1 would protect cells from ABT-737-induced cell death and whether this would be Puma dependent. Flag-tagged Mcl-1 was transiently transfected in control and Puma-/- cells, cells were treated with a high concentration of ABT-737, and the percentage of Flag-positive cells exhibiting active caspase 3 was evaluated by immunocytochemistry. Although, in a Puma-proficient context, the percentage of cells displaying caspase 3 activation after ABT-737 treatment was lower in the Flag-Mcl-1-expressing population than in the mock-transfected one, this was not the case in a Puma-deficient background (Fig. 6 C). This puts forth the notion that Mcl-1 regulates ABT-737-induced cell death in great part in these cells by antagonizing Puma. It implies that Puma exerts proapoptotic activity that is efficient in the absence of Bcl-xL and Mcl-1 and that is restrained by these proteins.
###end p 31
###begin title 32
###xml 78 82 <span type="species:ncbi:9696">Puma</span>
Pharmacological inhibition of Bcl-xL enhances interactions between endogenous Puma and Bax
###end title 32
###begin p 33
###xml 546 552 542 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 567 575 563 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 708 711 704 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 704 711 700 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 719 727 715 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 1037 1040 1033 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1033 1040 1029 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 1179 1187 1175 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1351 1359 1347 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 56 60 <span type="species:ncbi:9696">Puma</span>
###xml 212 216 <span type="species:ncbi:9696">Puma</span>
###xml 373 377 <span type="species:ncbi:9696">Puma</span>
###xml 704 708 <span type="species:ncbi:9696">Puma</span>
###xml 872 876 <span type="species:ncbi:9696">Puma</span>
###xml 1033 1037 <span type="species:ncbi:9696">Puma</span>
###xml 1162 1166 <span type="species:ncbi:9696">Puma</span>
###xml 1263 1267 <span type="species:ncbi:9696">Puma</span>
###xml 1405 1409 <span type="species:ncbi:9696">Puma</span>
###xml 1587 1591 <span type="species:ncbi:9696">Puma</span>
###xml 1675 1679 <span type="species:ncbi:9696">Puma</span>
The aforementioned experiments show that the ability of Puma to mediate cell death induced by ABT-737-mediated Bcl-xL inhibition is independent from Mcl-1. They favor the notion that a direct interaction between Puma and Bax would be involved in this cell death process. We analyzed the effects of ABT-737 on intermolecular interactions between endogenous Bcl-xL, Bax, and Puma by coimmunoprecipitation experiments using lysates from cells treated with 1 microM ABT-737, which is an experimental condition that does not trigger major cell death (Fig. 4). As shown in Fig. 7 A, such treatment almost completely abolished the interactions between Bcl-xL and Bax in control cells. This was also the case in Puma-/- cells (Fig. 7 C). This indicates that inhibition of Bax-Bcl-xL interactions is not an indirect consequence of cell death induction. It implies that the role of Puma in ABT-737 activity is not to allow this compound to disrupt Bax-Bcl-xL complexes and, conversely, that disruption of Bax-Bcl-xL complexes that preexist in Puma-/- cells is insufficient to promote full-blown apoptosis. In control cells, ABT-737 also disrupted the interactions between Puma and Bcl-xL (Fig. 7 A). Most notably, coimmunoprecipitation showed that some interaction between Puma and Bax occurred in untreated cells and that it was enhanced by ABT-737 treatment (Fig. 7 B). Thus, ABT-737 treatment frees both Bax and Puma from Bcl-xL and allows these two proteins to interact substantially. Collectively, these assays suggest that the BH3-binding activity of Bcl-xL maintains survival by preventing Puma and Bax to interact with each other. Because some interaction was detected between Puma and Bax in viable cells, Bcl-xL may also protect cells from the consequence of these interactions.
###end p 33
###begin p 34
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of ABT-737 on intermolecular interactions involving Bax, Bcl-xL, and Puma.</bold>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup></italic>
###xml 1109 1112 1105 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1116 1119 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1106 1119 1102 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup>Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 1230 1231 1224 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 76 80 <span type="species:ncbi:9696">Puma</span>
###xml 125 129 <span type="species:ncbi:9696">Puma</span>
###xml 362 366 <span type="species:ncbi:9696">Puma</span>
###xml 457 461 <span type="species:ncbi:9696">Puma</span>
###xml 686 690 <span type="species:ncbi:9696">Puma</span>
###xml 801 805 <span type="species:ncbi:9696">Puma</span>
###xml 1037 1041 <span type="species:ncbi:9696">Puma</span>
###xml 1112 1116 <span type="species:ncbi:9696">Puma</span>
Effect of ABT-737 on intermolecular interactions involving Bax, Bcl-xL, and Puma. (A) Interactions between Bcl-xL and Bax or Puma. HCT116 p21-/- cells were treated or not treated (-) with 1 microM ABT-737 for 24 h. Cell lysates were immunoprecipitated (IP) with an anti-Bcl-xL antibody as described in Materials and methods, and the presence of Bcl-xL, Bax, and Puma in the immunoprecipitated fractions was analyzed by immunoblotting. The amount of Bax and Puma that were coimmunoprecipitated with Bcl-xL in each condition was evaluated by densitometric analysis and normalized to the amount of protein that coimmunoprecipitated with Bcl-xL in untreated cells. (B) Interactions between Puma and Bax. Experiments were performed as in A using an anti-Bax antibody for immunoprecipitation. The amount of Puma that was coimmunoprecipitated with Bax in each condition (evaluated by densitometric analysis) was normalized to the amount of protein that coimmunoprecipitated with Bax in treated cells. (C) Interactions between Bcl-xL and Bax in Puma knockout cells. Experiments were performed as in A using HCT116 p21-/-Puma-/- cells. (A-C) Data are mean +/- SEM of three independent experiments. P-values were assessed using a Student's t test. WB, Western blot.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 428 447 428 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Lovell et al., 2008</xref>
###xml 155 159 <span type="species:ncbi:9696">Puma</span>
###xml 738 742 <span type="species:ncbi:9696">Puma</span>
Although it has been proposed that Bax activation may be initiated by a subgroup of BH3 domains, so far, it has remained unclear whether the BH3 domain of Puma classifies as an activator. Analysis of Bax activation by truncated Bid in model assays has put forth the notion that Bax activation is a stepwise mechanism that relies on a series of reversible binding interactions with different rates initiated by transient events (Lovell et al., 2008). Thus, an initiating interaction between Bax and an activating BH3 domain may be elusive because of its fugacious nature and because of its potent inhibition by BH3-binding Bcl-2 homologues, which maintain cell survival. Thus, our analysis of a physical and functional interaction between Puma and Bax was focused on the definition of molecular motifs involved in this interaction and on the investigation of its consequences in cellular contexts in which Bcl-2 homologues are absent and/or inhibited.
###end p 36
###begin p 37
###xml 228 249 224 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 453 456 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 688 709 680 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 857 860 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 987 1004 971 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Wang et al., 1996</xref>
###xml 1528 1552 1500 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Gavathiotis et al., 2008</xref>
###xml 2023 2044 1995 2016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Yee and Vousden, 2008</xref>
###xml 23 27 <span type="species:ncbi:9696">Puma</span>
###xml 98 102 <span type="species:ncbi:9696">Puma</span>
###xml 397 401 <span type="species:ncbi:9696">Puma</span>
###xml 678 682 <span type="species:ncbi:9696">Puma</span>
###xml 1110 1114 <span type="species:ncbi:9696">Puma</span>
###xml 1238 1242 <span type="species:ncbi:9696">Puma</span>
###xml 1613 1617 <span type="species:ncbi:9696">Puma</span>
###xml 1869 1873 <span type="species:ncbi:9696">Puma</span>
###xml 1935 1939 <span type="species:ncbi:9696">Puma</span>
###xml 1967 1971 <span type="species:ncbi:9696">Puma</span>
We recently found that Puma could interact with the first alpha helix of Bax and then showed that Puma or its BH3 domain could promote Bax interaction with mitochondria in cell-free assays and trigger its proapoptotic activity (Cartron et al., 2004a). The evidence provided in this study suggests that the latter effect involves, at least in part, a physical interaction between the BH3 domain of Puma and Bax, as the enhancement of Bax activity by PumaBH3 is prevented by a minimal peptide that prevents this physical interaction. This peptide was designed from a Pepscan analysis, which further substantiated our previous description of an interaction between Bax Halpha1 and Puma BH3 (Cartron et al., 2004a) and underscored the role of the C-terminal end of Bax Halpha1 in this interaction. Our analysis also hinted to a possible interaction between PumaBH3 and Bax Halpha4, which is close to the Bax BH1 domain that was initially suggested to play a role in an interaction with Bid (Wang et al., 1996). However, a 7-mer peptide comprising residues 92-98 (within Bax Halpha4) proved insufficient to prevent Puma BH3-Bax interactions in pull-down assays (unpublished data). The roles of other regions within Bax in its interaction with Puma also require further elucidation. In particular, a recent study published after submission of this manuscript shows that not only residues in Bax Halpha1 but also residues in Bax Halpha6 might be critically involved in ligand-induced activation of Bax by a stabilized Bim BH3 peptide (Gavathiotis et al., 2008). In our study, because Pepscan analysis using biotinylated Puma BH3 and peptides covering the sequence of Bax between residue 107 and residue 194 did not yield any significant result (unpublished data), we currently do not know whether, or which, additional regions in Bax might be involved in its interaction with Puma BH3. The involvement of regions other than the BH3 domain of Puma in the interaction between Puma and Bax has also been suggested by a recent study (Yee and Vousden, 2008).
###end p 37
###begin p 38
###xml 288 308 276 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Cartron et al., 2005</xref>
###xml 572 596 552 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Gavathiotis et al., 2008</xref>
###xml 718 738 698 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Lakhani et al., 2006</xref>
###xml 740 756 720 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">Zhu et al., 2006</xref>
###xml 891 910 867 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Bellot et al., 2007</xref>
###xml 1081 1102 1057 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Grinberg et al., 2005</xref>
###xml 388 392 <span type="species:ncbi:9696">Puma</span>
###xml 919 923 <span type="species:ncbi:9696">Puma</span>
In the native conformation of Bax, Bax Halpha1 is in the vicinity of Bax Halpha2, which contains the BH3 domain. Moreover, a salt bridge formed between D33 within the C-terminal end of Bax Halpha1 and K64 within the BH3 domain participates in the maintenance of Bax in an inactive state (Cartron et al., 2005). Thus, it is tempting to speculate that an intermolecular interaction between Puma BH3 and Bax Halpha1 might help to initiate an unfolding of the Bax molecule. This process, which could also play a role in Bax activation by Bim, as Bax Halpha1 is also involved (Gavathiotis et al., 2008), might allow the complete activation of Bax to occur, possibly in combination with additional amplificatory mechanisms (Lakhani et al., 2006; Zhu et al., 2006). It should be noted that Bax Halpha1 might be involved in other protein-protein interactions engaged by Bax such as that with TOM22 (Bellot et al., 2007). Thus, Puma and Bax may end up in distinct protein complexes during the course of cell death. This aspect is reminiscent of what was reported for the Bid-Bax interplay (Grinberg et al., 2005).
###end p 38
###begin p 39
###xml 241 261 241 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Arokium et al., 2004</xref>
###xml 623 641 619 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Weber et al., 2007</xref>
###xml 889 908 885 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kuwana et al., 2002</xref>
###xml 910 930 906 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Lalier et al., 2007b</xref>
###xml 1294 1312 1290 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Weber et al., 2007</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 303 307 <span type="species:ncbi:9696">Puma</span>
###xml 455 459 <span type="species:ncbi:9696">Puma</span>
###xml 513 517 <span type="species:ncbi:9696">Puma</span>
###xml 537 542 <span type="species:ncbi:4932">yeast</span>
###xml 964 968 <span type="species:ncbi:9696">Puma</span>
###xml 1133 1138 <span type="species:ncbi:4932">yeast</span>
###xml 1146 1150 <span type="species:ncbi:9696">Puma</span>
###xml 1347 1351 <span type="species:ncbi:9696">Puma</span>
###xml 1407 1412 <span type="species:ncbi:4932">yeast</span>
###xml 1437 1442 <span type="species:ncbi:4932">yeast</span>
###xml 1506 1510 <span type="species:ncbi:9696">Puma</span>
Yeast cells, which express no recognized Bcl-2 family proteins, tolerate the heterologous expression of wild-type, untagged Bax but undergo mitochondrial permeabilization and cell death when expressing constitutively active variants of Bax (Arokium et al., 2004). Thus, the fact that, in this paradigm, Puma physically interacts with Bax and switches on its killing activity by a Bax Halpha1-, Bcl-xL-sensitive process strongly underscores the potency of Puma to initiate Bax activation by itself. The ability of Puma to activate Bax in yeast is reminiscent of a similar effect recently reported for the short form of Bim (Weber et al., 2007). This work implies that the interaction of Bim with mitochondria is critical and that mechanisms other than protein-protein interactions could be at stake. Bax-activating signals can be provided by nonfamily proteins or nonproteinaceous factors (Kuwana et al., 2002; Lalier et al., 2007b). Therefore, it is possible that Puma may have an impact on such mechanisms, having an effect that, added to its ability to interact with Bax, will lead to efficient cell death. As we observed that, in yeast cells, Puma is essentially cytosolic (unpublished data), such additional signals would rely on different molecular mechanisms than those proposed for Bim (Weber et al., 2007). Because expression of cytosolic Puma leads to an accumulation of Bax at the mitochondria in yeast (unpublished data), the yeast system argues for a "touch and go" type of interaction between Puma and Bax.
###end p 39
###begin p 40
###xml 440 468 440 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Del Gaizo Moore et al., 2007</xref>
###xml 201 205 <span type="species:ncbi:9696">Puma</span>
###xml 596 600 <span type="species:ncbi:9696">Puma</span>
###xml 891 895 <span type="species:ncbi:9696">Puma</span>
###xml 924 928 <span type="species:ncbi:9696">Puma</span>
###xml 1096 1100 <span type="species:ncbi:9696">Puma</span>
###xml 1244 1248 <span type="species:ncbi:9696">Puma</span>
A genuine activator BH3-only protein is expected to play an active role when mammalian cell death is induced by inhibition of Bcl-2 homologues. Along this line, it is important to note that endogenous Puma is involved in efficient induction of apoptosis in HCT116 cells by the small compound ABT-737. Although other death agonist BH3-only proteins might be mediators of ABT-737-induced cell death in certain cell systems (most notably Bim; Del Gaizo Moore et al., 2007), knockdown of Bim and Bid expression in HCT116 cells had no detectable impact on ABT-737-induced cell death (), implying that Puma's role in this case is not upstream of these proteins. Likewise, down-regulation of Bak had no detectable effect on ABT-737 induction of cell death in the same cells (Fig. S4 B), suggesting that this protein is also dispensable for this process and underlining the major role played by the Puma-Bax axis. Most importantly, Puma is involved in ABT-737-induced cell death even in conditions under which Mcl-1 expression is down-regulated, and, on a molecular level, ABT-737 treatment enhances Bax-Puma interactions at the same time as it prevents the interaction of each of these proteins with Bcl-xL. These observations support the notion that Puma is a death agonist BH3-only protein that, as such, provides a tonic death signal that the combined BH3-binding activities of Bcl-2 homologues will have to continuously counterbalance to maintain survival.
###end p 40
###begin p 41
###xml 725 742 725 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Ming et al., 2006</xref>
###xml 65 69 <span type="species:ncbi:9696">Puma</span>
###xml 690 694 <span type="species:ncbi:9696">Puma</span>
This notion is best exemplified by our observation that although Puma or Bax knockout cells tolerate Bcl-xL down-regulation, control HCT116 cells undergo massive cell death after such down-regulation. Compared with Bcl-xL down-regulation, Bcl-2 down-regulation (unpublished data) and Mcl-1 down-regulation (at the very least in the experimental conditions used) only had a modest effect on the viability of HCT116 cells. This indicates that Bcl-xL is more critically involved in maintaining the survival of these cells than its homologues. The reason for this apparent selectivity is unclear, but, strikingly, it recalls a previous study that showed that Bcl-xL much more potently prevents Puma function than Bcl-2 or Mcl-1 (Ming et al., 2006).
###end p 41
###begin p 42
###xml 354 373 354 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Chipuk et al., 2005</xref>
###xml 375 392 375 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Ming et al., 2006</xref>
###xml 394 415 394 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Yee and Vousden, 2008</xref>
###xml 690 706 690 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Kim et al., 2006</xref>
###xml 708 727 708 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Willis et al., 2007</xref>
###xml 1215 1234 1215 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Moreau et al., 2003</xref>
###xml 1236 1256 1236 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Cartron et al., 2005</xref>
###xml 27 31 <span type="species:ncbi:9696">Puma</span>
###xml 128 132 <span type="species:ncbi:9696">Puma</span>
###xml 256 260 <span type="species:ncbi:9696">Puma</span>
###xml 327 331 <span type="species:ncbi:9696">Puma</span>
###xml 446 450 <span type="species:ncbi:9696">Puma</span>
###xml 647 651 <span type="species:ncbi:9696">Puma</span>
###xml 668 672 <span type="species:ncbi:9696">Puma</span>
###xml 757 761 <span type="species:ncbi:9696">Puma</span>
###xml 827 831 <span type="species:ncbi:9696">Puma</span>
###xml 1313 1317 <span type="species:ncbi:9696">Puma</span>
Importantly, low levels of Puma appear sufficient to prime cells to death and lock them in a Bcl-xL-dependent state. Thus, when Puma expression is increased, it is possible that its accumulation in complexes with Bcl-xL (and thus the ability of additional Puma molecules to interact with Bcl-xL) may play a significant role in Puma-dependent cell death (Chipuk et al., 2005; Ming et al., 2006; Yee and Vousden, 2008). Another implication is that Puma may exert a proapoptotic function that will be lost only when its expression is completely abrogated. This may explain differences found between experiments that, albeit performed similarly, used Puma knockout versus Puma knockdown cells (Kim et al., 2006; Willis et al., 2007). It is also noteworthy that Puma knockout HCT116 cells still show some response to ABT-737. Thus, Puma expression may not be an absolute requirement for induction of cell death by Bcl-xL inhibition. Along this line, it is important to note that we have shown that survival antagonist BH3 domains could promote the release of active Bax from Bcl-xL by themselves, implying that sensitizer molecules can launch a Bax-dependent apoptotic program without additional Bax-activating signals (Moreau et al., 2003; Cartron et al., 2005). The ability of ABT-737 to displace Bax from Bcl-xL in Puma-deficient cells may account for the small rates of Bax-dependent cell death we observed in these cells.
###end p 42
###begin p 43
###xml 349 373 349 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Nakano and Vousden, 2001</xref>
###xml 375 390 375 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Yu et al., 2001</xref>
###xml 392 418 392 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Hershko and Ginsberg, 2004</xref>
###xml 420 439 420 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Melino et al., 2004</xref>
###xml 441 457 441 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">You et al., 2006</xref>
###xml 176 180 <span type="species:ncbi:9696">Puma</span>
###xml 279 283 <span type="species:ncbi:9696">Puma</span>
###xml 672 676 <span type="species:ncbi:9696">Puma</span>
With increasing evidence of secondary effects and possible acquisition of resistance to ABT-737, predictive markers of sensitivity and resistance to this compound are crucial. Puma expression can be driven downstream of diverse tumor suppressor and/or oncogenic pathways because Puma is a direct transcription target of p53, p73, Foxo3A, and E2F-1 (Nakano and Vousden, 2001; Yu et al., 2001; Hershko and Ginsberg, 2004; Melino et al., 2004; You et al., 2006). Our results suggest that these pathways might install some sensitivity to wide-range or selective inhibitors of Bcl-2 homologues in cancer cells. Conversely, posttranslational mechanisms that negatively regulate Puma activity and allow cells to accumulate this protein without undergoing cell death are expected to promote resistance against such inhibitors.
###end p 43
###begin title 44
Materials and methods
###end title 44
###begin title 45
Cell culture and cell lines
###end title 45
###begin p 46
###xml 49 69 49 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Cartron et al., 2003</xref>
###xml 158 179 154 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 242 261 238 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Manero et al., 2006</xref>
###xml 324 327 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 321 327 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup></italic>
###xml 332 335 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 339 342 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 329 342 325 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup>Puma<sup>&#8722;/&#8722;</sup></italic>
###xml 351 354 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 357 360 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 348 360 344 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>&#8722;/&#8722;</sup>Bax<sup>&#8722;/&#8722;</sup></italic>
###xml 448 463 444 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Yu et al., 2003</xref>
###xml 264 269 <span type="species:ncbi:9606">Human</span>
###xml 335 339 <span type="species:ncbi:9696">Puma</span>
BdGBM and BeGBM cells were described previously (Cartron et al., 2003). BdGBM(Bax-alpha), BdGBM(BaxD33A), and BdGBM(BaxK64A) cells were described previously (Cartron et al., 2004a). GBM shBax and GBM scr cells were also described previously (Manero et al., 2006). Human colorectal cancer cells lines derived from HCT116 (p21-/-, p21-/-Puma-/-, and p21-/-Bax-/-) were provided by B. Vogelstein (The John Hopkins Kimmel Cancer Center, Baltimore, MD; Yu et al., 2003). GBM samples were provided by S. Martin (Hopital G et R Laennec, Centre Hospitalier Universitaire, Nantes, France) and M. Campone (Centre Rene Gauducheau, Nantes-Atlantique, Nantes, France).
###end p 46
###begin title 47
Antibodies
###end title 47
###begin p 48
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 256 260 <span type="species:ncbi:9696">Puma</span>
###xml 365 376 <span type="species:ncbi:3704">Horseradish</span>
Anti-Bcl-xL (for immunoprecipitation [Epitomics] and for Western blotting [Transduction Laboratory]), anti-Bax 2D2 (for immunoprecipitation [Sigma-Aldrich] and for Western blotting [Dako]), anti-cytochrome c (R&D Systems), anti-active caspase 3 (BD), anti-Puma (Sigma-Aldrich), anti-Mcl-1 (Tebu-bio), antiactin (Millipore), and anti-Flag (Sigma-Aldrich) were used. Horseradish peroxidase-conjugated antibodies and enhanced chemiluminescence reagents were obtained from Santa Cruz Biotechnology, Inc. Fluorescent secondary antibodies were obtained from Invitrogen.
###end p 48
###begin title 49
Peptides, recombinant proteins, and peptide scan
###end title 49
###begin p 50
###xml 191 211 191 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Cartron et al., 2002</xref>
###xml 378 397 378 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Bellot et al., 2007</xref>
###xml 429 432 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
###xml 568 579 <span type="species:ncbi:3704">horseradish</span>
Peptides () were obtained from Sigma-Aldrich and NeoMPS Polypeptide Laboratories. Small-scale preparation of recombinant His-Bax from bacterial lysates was performed as described previously (Cartron et al., 2002). Peptide scanning was performed as previously described using nitrocellulose membranes on which 12-mer peptides covering the indicated sequence of Bax were spotted (Bellot et al., 2007). 1 microg/ml biotinylated PumaBH3 was incubated with membranes overnight at 4degreesC and, after three washes with PBS and 1% BSA, was detected using extravidin-coupled horseradish peroxidase. Binding intensities were quantified using IP Laboratory Gel software (Signal Analytics).
###end p 50
###begin title 51
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast assays
###end title 51
###begin p 52
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1/10</italic>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIS3</italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRP1</italic>
###xml 356 376 356 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Arokium et al., 2004</xref>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 768 769 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 795 815 795 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Arokium et al., 2004</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 70 74 <span type="species:ncbi:9696">Puma</span>
###xml 317 322 <span type="species:ncbi:4932">yeast</span>
###xml 390 394 <span type="species:ncbi:9696">Puma</span>
Yeast-expressing galactose-inducible Bax (or BaxD33A), Bcl-xL, and/or Puma was obtained by transforming the wild-type haploid strain W303-1B (Mata, ade2, his3, leu2, trp1, and ura3) with expression vectors expressing the corresponding cDNA under control of the GAL1/10 promoter and expressing URA3, HIS3, and TRP1 as yeast selection markers, respectively (Arokium et al., 2004). A chimeric Puma cDNA optimized for expression (Genescript) was used (Table S1). Survival after the addition of 0.5% galactose to cultures in early exponential growth phase was evaluated by plating 250 cells on complete medium and counting formed colonies 48 h later. Cytochrome c release was measured by redox spectrometry on isolated mitochondria as previously described using cytochrome b as an internal standard (Arokium et al., 2004). Immunoprecipitation experiments were performed with the IP-50 immunoprecipitation kit (Sigma-Aldrich) according to the manufacturer's instructions, using 2 microg of antibody and 2-5 mg of protein from zymolyase-treated whole cell lysates in 500 microl IP-50 buffer (Sigma-Aldrich).
###end p 52
###begin title 53
Pull-down assays
###end title 53
###begin p 54
###xml 26 29 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BH3</sup>
1 microM biotinylated PumaBH3 was incubated with 500 microg of GBM cell extract in 500 microl of CHAPS buffer (10 mM Hepes, 150 mM NaCl, 1% CHAPS, pH 7.4, and EDTA-free protease inhibitors cocktail) with or without the competing peptide for 2 h under agitation at 4degreesC. 30 microl of avidin-agarose beads, previously washed twice with CHAPS buffer, were then added and incubated overnight under agitation at 4degreesC. After three washes in 500 microl of CHAPS buffer, beads were resuspended in 30 microl of 2x Laemmli buffer and boiled for 30 s at 95degreesC before Western blotting.
###end p 54
###begin title 55
RNA interference and transfection assays
###end title 55
###begin p 56
###xml 76 92 76 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Qin et al., 2003</xref>
###xml 263 268 <span type="species:ncbi:9606">human</span>
Lentivirus production and titration were performed as described previously (Qin et al., 2003) using HEK293-FT as packaging cells and FG12 lentivector in which an scr negative control (Applied Biosystems) or short hairpin RNA targeted to oligonucleotides 58-76 of human Bcl-xL under the control of the U6 promoter were subcloned. A multiplicity of infection of 4 was used. Mcl-1 and control siRNA were purchased from Applied Biosystems. Cells were transfected using the HiPerfect transfection reagent (QIAGEN) according to the manufacturer's instructions and were incubated with nucleotides for 48 h before subsequent experiments. Transfection with plasmids was performed using Lipofectamine 2000 reagent (Sigma-Aldrich) according to the manufacturer's instructions.
###end p 56
###begin title 57
Cellular assays
###end title 57
###begin p 58
###xml 116 137 116 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cartron et al., 2004a</xref>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 676 682 <span type="species:ncbi:9986">rabbit</span>
Cytoplasmic microinjection and morphological analysis of cell death in fluorescent cells were described previously (Cartron et al., 2004a). For immunocytochemical assays, cells were washed with PBS and fixed with 4% paraformaldehyde and 0.15% picric acid in PBS for 30 min at RT. Cells were washed three times in PBS and permeabilized with 0.1% SDS in PBS for 10 min at RT. Cells were washed again and, after a 30-min saturation with 5% gelatin in PBS at 37degreesC, were incubated with primary antibodies diluted in 1% gelatin in PBS for 1.5 h at 37degreesC. After three washes in PBS, incubation with secondary antibodies (anti-mouse IgG coupled to Alexa Fluor 488 and anti-rabbit IgG coupled to Alexa Fluor 568) was performed in 1% gelatin in PBS for 1.5 h at 37degreesC. Cells were then washed and mounted in ProLong Gold antifade reagent (Invitrogen). Cells that had not been infected with lentivirus were inspected at RT with a fluorescent microscope (BX60; Olympus) equipped with a 40x NA 0.75 objective lens (UPlanFL) and a digital camera (CoolSNAP EZ; Photometrics). Representative images were acquired by MetaVue software (MDS Analytical Technologies). Lentivirus-infected cells were inspected at RT with a fluorescent microscope (DMLB; Leica) equipped with a 40x NA 0.75 objective lens (HCxPL FluoTar) and a color digital camera (DC300F; Leica). Representative images were acquired with the IM50 Image Manager software (Leica). Coimmunoprecipitation assays, using 2 microg of the indicated antibody and 500 microg of protein lysates in CHAPS buffer, were performed with the IP-50 immunoprecipitation kit according to manufacturer's recommendations. For long-term assays, 500 cells were seeded in each well of a 6-well plate 24 h before the start of a 2-wk continuous treatment, after which cells were stained with 0.5% crystal violet and 20% methanol.
###end p 58
###begin title 59
Online supplemental material
###end title 59
###begin p 60
###xml 121 125 <span type="species:ncbi:9696">Puma</span>
###xml 202 206 <span type="species:ncbi:9696">Puma</span>
###xml 399 403 <span type="species:ncbi:9696">Puma</span>
Fig. S1 shows physical and functional interactions of Bax with BH3 peptides. Fig. S2 shows the impact of Halpha1-Cter on Puma induction of apoptosis. Fig. S3 shows additional data regarding the role of Puma in ABT-737 induction of cell death. Fig. S4 shows the lack of contribution of Bid, Bim, and Bak in ABT-737 induction of cell death in HCT116 cells. Table S1 shows sequences of peptides and of Puma cDNA used in this study. Online supplemental material is available at .
###end p 60
###begin title 61
Supplementary Material
###end title 61
###begin title 62
[Supplemental Material Index]
###end title 62
###begin p 63
We thank Stephane Martin and Mario Campone for GBM samples. We thank the Gliome Grand Ouest network for the Sigma-Aldrich consortium MISSION lentiviral transduction particles. We thank Bert Vogelstein for the gift of cell lines and Peter Daniel for his help and criticism throughout this study. We thank Frederique Braun, Fanny Marhuenda, Gregory Bellot, and Sophie Barille-Nion for fruitful comments and for their help. We are particularly indebted to Jean Claude Martinou for his help and criticism.
###end p 63
###begin p 64
E. Hervouet is supported by a postdoctoral fellowship from the Institut National du Cancer, and F. Gautier is supported by a postdoctoral fellowship from the Region Pays de la Loire. F.M. Vallette and S. Manon are supported by the Agence Nationale de la Recherche (Mechanism of Activation of Bax project). S. Manon is supported by the Association pour la Recherche contre le Cancer (ARC; grant 3812). P. Juin is supported by the Region Pays de la Loire (Ciblage Moleculaire a Application Therapeutique network), ARC (grant 3875), Fondation de France, and Institut de Recherche Servier.
###end p 64
###begin article-title 65
The Bcl-2 apoptotic switch in cancer development and therapy.
###end article-title 65
###begin article-title 66
###xml 62 67 <span type="species:ncbi:4932">yeast</span>
Studies of the interaction of substituted mutants of BAX with yeast mitochondria reveal that the C-terminal hydrophobic alpha-helix is a second ART sequence and plays a role in the interaction with anti-apoptotic BCL-xL.
###end article-title 66
###begin article-title 67
Substitutions of potentially phosphorylatable serine residues of Bax reveal how they may regulate its interaction with mitochondria.
###end article-title 67
###begin article-title 68
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax.
###end article-title 68
###begin article-title 69
Distribution of binding sequences for the mitochondrial import receptors Tom20, Tom22, and Tom70 in a presequence-carrying preprotein and a non-cleavable preprotein.
###end article-title 69
###begin article-title 70
Involvement of the N-terminus of Bax in its intracellular localization and function.
###end article-title 70
###begin article-title 71
Nonredundant role of Bax and Bak in Bid-mediated apoptosis.
###end article-title 71
###begin article-title 72
The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA.
###end article-title 72
###begin article-title 73
The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein.
###end article-title 73
###begin article-title 74
Distinct domains control the addressing and the insertion of Bax into mitochondria.
###end article-title 74
###begin article-title 75
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
###end article-title 75
###begin article-title 76
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.
###end article-title 76
###begin article-title 77
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
###end article-title 77
###begin article-title 78
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.
###end article-title 78
###begin article-title 79
BAX activation is initiated at a novel interaction site.
###end article-title 79
###begin article-title 80
Mitochondrial carrier homolog 2 is a target of tBID in cells signaled to die by tumor necrosis factor alpha.
###end article-title 80
###begin article-title 81
Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis.
###end article-title 81
###begin article-title 82
###xml 0 4 <span type="species:ncbi:9696">Puma</span>
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.
###end article-title 82
###begin article-title 83
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
###end article-title 83
###begin article-title 84
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.
###end article-title 84
###begin article-title 85
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
###end article-title 85
###begin article-title 86
Caspases 3 and 7: key mediators of mitochondrial events of apoptosis.
###end article-title 86
###begin article-title 87
Bax activation and mitochondrial insertion during apoptosis.
###end article-title 87
###begin article-title 88
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Increase in PGE(2) biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme.
###end article-title 88
###begin article-title 89
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
###end article-title 89
###begin article-title 90
Diagnosing and exploiting cancer's addiction to blocks in apoptosis.
###end article-title 90
###begin article-title 91
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax.
###end article-title 91
###begin article-title 92
Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1.
###end article-title 92
###begin article-title 93
The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
###end article-title 93
###begin article-title 94
p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation.
###end article-title 94
###begin article-title 95
PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells.
###end article-title 95
###begin article-title 96
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
###end article-title 96
###begin article-title 97
PUMA, a novel proapoptotic gene, is induced by p53.
###end article-title 97
###begin article-title 98
An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
###end article-title 98
###begin article-title 99
Structural biology of the Bcl-2 family of proteins.
###end article-title 99
###begin article-title 100
###xml 89 94 <span type="species:ncbi:4932">yeast</span>
Investigation of the role of the C-terminus of Bax and of tc-Bid on Bax interaction with yeast mitochondria.
###end article-title 100
###begin article-title 101
Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins.
###end article-title 101
###begin article-title 102
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.
###end article-title 102
###begin article-title 103
Structure of Bax: coregulation of dimer formation and intracellular localization.
###end article-title 103
###begin article-title 104
###xml 72 76 <span type="species:ncbi:9696">puma</span>
p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.
###end article-title 104
###begin article-title 105
BID: a novel BH3 domain-only death agonist.
###end article-title 105
###begin article-title 106
BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins.
###end article-title 106
###begin article-title 107
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.
###end article-title 107
###begin article-title 108
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
###end article-title 108
###begin article-title 109
Contribution of membrane localization to the apoptotic activity of PUMA.
###end article-title 109
###begin article-title 110
###xml 31 35 <span type="species:ncbi:9696">Puma</span>
FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal.
###end article-title 110
###begin article-title 111
PUMA induces the rapid apoptosis of colorectal cancer cells.
###end article-title 111
###begin article-title 112
PUMA mediates the apoptotic response to p53 in colorectal cancer cells.
###end article-title 112
###begin article-title 113
Bax does not have to adopt its final form to drive T cell death.
###end article-title 113
###begin p 114
###xml 151 155 <span type="species:ncbi:9696">Puma</span>
Abbreviations used in this paper: BdGBM, Bax-deficient GBM; BeGBM, Bax-expressing GBM; GBM, glioblastoma multiforme; Halpha1-Cter, Halpha1 C terminus; Puma, p53 up-regulated modulator of apoptosis; scr, scramble.
###end p 114

